Spinal Myeloid Sarcoma "Chloroma" Presenting as Cervical Radiculopathy: Case Report.

Study Design Case report. Objective Myeloid sarcoma (also known as chloroma) is a rare, extramedullary tumor composed of immature granulocytic cells. It may occur early in the course of acute or chronic leukemia or myeloproliferative disorders. Spinal cord invasion by myeloid sarcoma is rare. The authors report a rare case of spinal myeloid sarcoma presenting as cervical radiculopathy. Methods A previously healthy 43-year-old man presented with progressive neck, right shoulder, and arm pain. Cervical magnetic resonance imaging (MRI) revealed a very large enhancing extradural soft tissue mass extending from C7 through T1, with severe narrowing of the thecal sac at the T1 level. The patient underwent posterior cervical open biopsy, laminectomy, and decompression. Histologic examination of the surgical specimen confirmed the diagnosis of myeloid sarcoma. Postoperatively, a bone marrow biopsy was done, which showed myeloproliferative neoplasm with eosinophilia. The patient then received systemic chemotherapy and radiotherapy. Results At the 10-month follow-up, the patient reported complete relief of arm pain and neck pain. X-rays showed that the overall cervical alignment was intact and there was no evidence of a recurrent lesion. MRI showed no evidence of compressive or remnant lesion. Conclusions Spinal myeloid sarcoma presenting as cervical radiculopathy is rare, and it may be easily misdiagnosed. Knowledge of its clinical presentation, imaging, and histologic characterization can lead to early diagnosis and appropriate treatment.

Introduction

Myeloid sarcoma (also known as granulocytic sarcoma or chloroma) is a rare, extramedullary tumor of immature myeloid cells. It more often develops in the setting of acute myeloid leukemia (AML), but it can also occur in association with chronic myeloid leukemia, myelodysplastic syndrome, or, rarely, in the absence of marrow involvement.1 The clinical presentation of myeloid sarcomas varies, and it is largely dependent on the site of involvement. The most common locations include the skin, soft tissue, bone, periosteum, and lymph nodes.1 Spinal epidural myeloid sarcoma is uncommon, and spinal cord compression caused by a myeloid sarcoma is exceptionally rare.

Here we report an unusual case of cervical radiculopathy as the first presentation of a spinal epidural myeloid sarcoma. The patient was successfully treated by spinal decompression and subsequent chemotherapy and radiation.

Case Report

History and Examination

A 43-year-old man presented with progressive neck, right shoulder, and arm pain of about 2 weeks' duration. The patient described that the pain radiated down his right upper extremity through the triceps region, into the forearm, and onto the fourth and fifth digits. There was no precipitating factor such as injury or trauma. The patient initially sought care with a chiropractor and a nurse practitioner and received various treatments including massage, cervical adjustment, intramuscular steroid injection, and steroid pack. He was also prescribed muscle relaxants and narcotic analgesics. Despite these interventions, his pain continued to increase. On physical examination, the patient was noted to be splinting his neck and actively resisting any neck motion. There was tenderness palpable over the right scapular border. There was decreased sensation on the ulnar aspect of his right hand as well as decreased pinch strength and sensation in the right fourth and fifth digits. There was also decreased sensation to pinprick over the entire right scapula. X-ray examination showed mild, multilevel cervical degenerative changes with spurring noted at the C5, C6, and C7 levels, but the disk height was relatively well maintained (Fig. 1). Cervical magnetic resonance imaging (MRI) revealed a very large, enhancing extradural soft tissue mass extending from C7 through T1 with severe narrowing of the thecal sac at the T1 level. There was also a large soft tissue mass to the right of midline from C7 to T2 with some areas of decreased or absent enhancement suggesting necrosis or developing phlegmon or abscess (Fig. 2).

Fig. 1

(A–C) Anteroposterior and lateral extension and flexion X-rays showed mild multilevel cervical degenerative changes with spurring noted at C5–C7. Disk height was relatively well maintained.

Fig. 2

Cervical magnetic resonance imaging showing the enhancing extradural soft tissue mass extending from C7 through T1 with severe narrowing of the thecal sac at T1 level. (A, B) T2-weighted images; (C, D) T1-weighted images.

Operation

In view of the patient's progressive neurologic symptoms and signs, combined with the MRI findings, we elected to decompress the spine and obtain an open definitive biopsy through a tumor-type approach. The risks, benefits, and alternatives to various diagnostic and therapeutic measures, including the merits of a needle biopsy, were initially discussed with the patient, and considering that the needle biopsy itself carries risk and the likelihood of a false-negative biopsy was quite high, we recommended and he decided to proceed with the definitive procedure. The patient then underwent a posterior cervical open biopsy, laminectomy, and tumor decompression. The large epidural mass indenting the thecal sac was totally removed during the surgery, and there were no intraoperative complications. Histologic examination showed extensive involvement by a hematopoietic neoplasm composed of atypical cells with irregular nuclei and delicate chromatin. Many immature eosinophils were noted, accompanying the neoplasm. The neoplastic cells infiltrated skeletal muscle fibers, fibrous tissue, and fat. A few mitotic figures were present. A few neoplastic cells showed indented nuclear membranes (Fig. 3). Immunohistochemical stains showed extensive positive staining in the atypical cells with CD43, as well as focal staining in these cells with CD10, CD34, CD 68, CD117, and lysozyme also noted (Fig. 4). CD3 and CD20 stains showed a few reactive T and B cells. S-100 stain showed nonspecific granular staining in the immature eosinophils. No staining with CD30 was noted. Cytogenetic fluorescence in situ hybridization analysis performed on the paraffin-embedded sections from the paraspinal mass was positive for deletion of the CHIC2 gene, indicating fusion of FIP1L1/PDGFRA. The morphologic and immunologic features led to the diagnosis of myeloid sarcoma.

Fig. 3

(A, B) Histologic examination showed extensive involvement by a hematopoietic neoplasm composed of atypical cells with irregular nuclei and delicate chromatin. Many immature eosinophils were noted accompanying the neoplasm.

Fig. 4

Immunohistochemical stains showed positive staining in the atypical cells with CD34 (A), CD117 (B), CD68 (C), and lysozyme (D).

Postoperative Course

The patient was referred to an oncologist postoperatively, and a subsequent bone marrow aspiration verified features of a myeloproliferative neoplasm with eosinophilia. The bone marrow also showed FIP1L1-PDGFRA rearrangement. Fluorescence in situ hybridization analysis on the bone marrow aspirate was positive for deletion of the CHIC2 gene in 28.5% of 200 interphase nuclei and was negative for BCR/ABL1, PDGFRB rearrangement, FGFR1 rearrangement, RUNX1T1/RUNX1, and MLL. The patient then received chemotherapy followed by radiation therapy. At his 10-month follow-up visit, the patient reported no arm pain, no neck pain, and significantly improved Neck Disability Index scores (Table 1). Physical examination showed 5 of 5 strength in his upper extremities. X-rays showed that the overall cervicothoracic junctional alignment was maintained, and there was no evidence of any new lesions (Fig. 5). MRI showed no evidence of compressive or remnant lesion (Fig. 6).

Table 1

Patient-reported outcome at the latest follow-up

	Preoperative	10 mo postoperative
Arm pain score (VAS)	8	0
Neck pain score (VAS)	4	0
NDI score	17	0

Abbreviations: NDI, Neck Disability Index; VAS, visual analog scale.

Fig. 5

(A, B) At the latest follow-up (10 months postoperative), anteroposterior and lateral X-rays showed that the overall cervical alignment was intact.

Fig. 6

(A, B) At the latest follow-up (10 months postoperative), magnetic resonance imaging showed no evidence of compressive or remnant lesion.

Discussion

Myeloid sarcoma was first described in 1811 and later named chloroma by King because of the green color caused by the presence of myeloperoxidase granules in the malignant myeloid cells.2 3 4 5 Overall, myeloid sarcoma represents a rare hematologic phenomenon with an incidence of 2.5 to 9.1% in patients with AML.1 6 It could occur concomitantly, following, or, rarely, before the onset of systemic bone marrow leukemia.1 6 7 The prevalence of myeloid sarcoma in the spine is estimated to be less than 1% among all patients with acute and chronic myeloid leukemia.5 All levels of the spine can be affected, but it seems more frequent in the lumbosacral spine, followed by the thoracic spine and cervical spine.5 The clinical manifestation of spinal myeloid sarcoma varies, and it largely depends on the tumor location and size. Spinal myeloid sarcoma that arises in the epidural or paraspinal tissues can present with signs of cord compression due to mass effect. In the presented case, the patient's initial presentation was neck, shoulder, and arm pain, and X-ray examination showed mild multilevel cervical degenerative changes. This unspecific presentation could easily be misdiagnosed with degenerative disk disease, which could lead to prolonged and inappropriate treatment and delay the timely diagnosis.

The diagnosis of spinal myeloid sarcoma is often challenging because the clinical and laboratory data are usually not contributory. The radiologic findings are usually nonspecific, and the mass often appears as a soft tissue mass on computed tomography or MRI.5 6 On MRI examination, myeloid sarcoma of the spine has a similar signal intensity to muscle on T1-weighted images and has an intermediate signal intensity on T2-weighted images.5 Immunohistochemistry is the most practical method for establishing the diagnosis of myeloid sarcoma, and a series of markers can be used for diagnosis confirmation and further lineage characterization.6 If the patient has established leukemia, the diagnosis of myeloid sarcoma is relatively straightforward, and it is suggested to always be included in the differential diagnosis for patients with AML who develop a soft tissue mass.6 The diagnosis of myeloid sarcoma could be difficult if there is no clinical history of leukemia. In this setting, every effort should be made to obtain a tissue diagnosis.6 In the present case, the patient underwent posterior cervical open biopsy, laminectomy, and tumor decompression, and immunohistochemical stains showed positive staining in the atypical cells with CD43, CD10, CD34, and CD117, which helped to confirm the diagnosis. Myeloid and lymphoid neoplasms with FIP1L1-PDGFRA fusion gene as shown in this case are extremely rare, and it is reported to have a striking, male predominance with features most commonly resembling chronic eosinophilic leukemia. It also rarely presents with concomitant AML, including myeloid sarcoma, and/or with concomitant T-cell lymphoblastic lymphoma.8 9

The treatment strategy for myeloid sarcoma largely depends on whether it develops at initial diagnosis or at relapse. The optimal timing and treatment of isolated myeloid sarcoma is still not clear; however, it has been reported that the patients who have delayed or inadequate systemic treatment of myeloid sarcoma will almost always progress to AML.9 For the patient with myeloid sarcoma who presents with concurrent marrow involvement, systemic treatment directed at the underlying leukemia is always suggested. A combined approach, such as surgical resection, chemotherapy, radiotherapy, and bone marrow transplantation, has been emphasized.6 10 Inoue et al11 identified 26 patients without leukemia with myeloid sarcoma from the literature, and they found that the treatment strategy varied individually. Surgical decompression was performed in 22 patients, and 21 of the patients received additional AML-type systemic treatment. However, the patients' outcome was generally poor, especially in the patients who showed progression to leukemia. Overall, prompt diagnosis and adequate treatment are essential to achieving a good outcome.6 12

Conclusion

We report a rare case of spinal myeloid sarcoma presenting as cervical radiculopathy. This may be easily misdiagnosed. Knowledge of its clinical presentation, imaging, and histologic characterization can lead to early diagnosis and appropriate treatment.

Commentary on: “Spinal Myeloid Sarcoma ‘Chloroma’ Presenting as Cervical Radiculopathy: Case Report”